Table 1.
Patient characteristics
| ALND | SLND | Total | p | |
|---|---|---|---|---|
| N | 30 | 176 | 206 | |
| Age at baseline | 0.132 | |||
| Mean (SD) | 58 (13.3) | 61.3 (12.6) | 60.8 (12.7) | |
| Median | 57.5 | 62 | 62 | |
| Range | 38, 38 | 24, 89 | 24, 89 | |
| BMI high | 14 (48%) | 83 (50%) | 97 (50%) | 1.000 |
| Final type of surgery M | 21 (70%) | 72 (41%) | 93 (45%) | 0.006 |
| Adjuvant Y | 17(57%) | 32 (18%) | 49 (23%) | <0.001 |
| Neo adjuvant Y | 7 (23%) | 3 (2%) | 10 (5%) | <0.001 |
| Taxane Y | 23 (77%) | 27 (15%) | 50 (23%) | <0.001 |
| Targeted (herceptin or TKI) Y | 2 (7%) | 7 (4%) | 9 (4%) | 0.855 |
| WB Y | 21 (70%) | 87 (49%) | 108 (50%) | 0.059 |
| Regional nodal irradiation Y | 19 (63%) | 22 (12%) | 41 (19%) | <0.001 |
| APBI Y | 1 (3%) | 19 (11%) | 20 (9%) | 0.346 |
ALND axillary lymph node dissection, SLNB sentinel lymph node biopsy, BMI body mass index, TKI tyrosine kinase inhibitor, WB whole breast irradiation, APBI accelerated partial breast irradiation